Genkyotex SA (EUR)
GKTX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.20 | 2.28
52-Wk Range- | -
Last Close2.19
Mkt Cap (m)25.28
Dividend yield-
ISINFR0013399474
Volume4,084.00
Exchange VenuePAR

Company Profile

Genkyotex SA is a biopharmaceutical company in NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes.

Key Information
Price/Earning-
Price/Book2.57
Price/Sales-
P/CF-
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-59.34
Debt/Equity0.09

Documents

Prospectus
en 10/03/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.genkyotex.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)0.000.000.000.000.790.00
Operating Income (m)-10.56-11.42-4.99-14.10-10.43-7.43
Net Income (m)-10.67-11.19-7.24-25.77-11.42-7.20
Basic EPS-7.67-7.17-4.68-3.88-1.49-0.88
Avg. Diluted Shares Outstanding (m)1.391.551.566.647.848.18
Balance Sheet
EUR201420152016201720182019
Current Assets (m)25.7820.3916.5016.5612.473.92
Non Current Assets (m)10.305.500.2210.349.739.27
Total Assets (m)36.0825.8916.7326.8922.2013.19
Current Liabilities (m)3.563.332.982.426.761.99
Total Liabilities (m)------
Total Equity (m)30.4920.3313.3023.5414.449.84
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)-9.85-11.74-8.19-9.36-8.87-7.59
Capital Expenditure (m)-0.07-0.15-0.010.000.000.00
Figures are quoted in EUR unless stated otherwise
0.01 (0.46%)
2.20
Last Price